UBS Group’s Amdocs DOX Stock Holding History

UBS Group’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,200	Closed	-$832K	–	7797
2018 Q4	$832K	Buy	+14,200	New	+$890K	﹤0.01%	3843
2018 Q2	–	Sell	-28,300	Closed	-$1.89M	–	8031
2018 Q1	$1.89M	Sell	28,300 -19,700	-41%	-$1.33M	﹤0.01%	3192
2017 Q4	$3.14M	Buy	48,000 +21,000	+78%	+$1.36M	﹤0.01%	2797
2017 Q3	$1.74M	Buy	27,000 +22,900	+559%	+$1.48M	﹤0.01%	3247
2017 Q2	$264K	Buy	4,100 +100	+3%	+$6.31K	﹤0.01%	4566
2017 Q1	$244K	Buy	+4,000	New	+$240K	﹤0.01%	4531
2016 Q2	–	Sell	-37,500	Closed	-$2.27M	–	7772
2016 Q1	$2.27M	Buy	+37,500	New	+$2.1M	﹤0.01%	2570

Other funds holding DOX

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group's DOX Position: Q2 2026 in Review

UBS Group reduced its Amdocs (DOX) stake by 45% in Q2 2026, selling an estimated $19.2M and leaving 384,062 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2717.

UBS Group first reported a position in DOX in Q4 2014 and has held it in 47 quarters since. The position peaked at $65.5M in Q3 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

UBS Group held 384,062 shares of Amdocs worth $19.4M as of Q2 2026.
UBS Group sold 312,646 Amdocs shares in Q2 2026, an estimated $19.2M.
Amdocs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2717 holding.
UBS Group first reported a position in Amdocs in Q4 2014 and has held it in 47 quarters since.
UBS Group's Amdocs position peaked at $65.5M in Q3 2025.
447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.